Tissue microarrays in Chinese human rectal cancer: Study of expressions of the tumor-associated genes

Hepato-Gastroenterology

Volumn 58, Issue 112, 2011, Pages 1937-1942

  Lin, Mao Song ^a   Chen, Wei Chang ^b   Huang, Jun Xing ^a   Gao, Heng Jun ^c   Zhang, Bao Feng ^d   Fang, Jing ^d   Zhou, Qiong ^d   Hu, Ying ^d  

^a TAIZHOU PEOPLE S HOSPITAL   (China)

^b SOOCHOW UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

^d National Engineering Center for Biochip   (China)

Author keywords

Immunohistochemical staining; Rectal cancer; Tissue microarray; Tumor associated gene

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLOOXYGENASE 2; MYC PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE A; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER TISSUE; CELL DIFFERENTIATION; CHINESE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM CANCER; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CYCLIN D1; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RECTAL NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 84863293422     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11262     Document Type: Article

References (36)

1. Midgley R, Kerr D: Colorectal cancer. Lancet 1999; 353:391-399. (Pubitemid 29088178)
2. Hermanek P, Hermanek PJ: Role of the surgeon as a variable in the treatment of rectal cancer. Semin Surg Oncol 2000; 4:329-335. (Pubitemid 32186923)
3. Kapiteljn E, Van de Velde CJ: Developments and quality assurance in rectal cancer surgery. Eur J Cancer 2002; 38:919-936.
4. Glynne-Jones R, Mathur P, Elton C, Train ML: The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer. Best Pract Res Clin Gastroenterol 2007; 21: 1049-1070.
5. Losi L, Baisse B, Bouzourene H, Benhattar J: Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis 2005; 26:916-922. (Pubitemid 41214320)
6. Arends JW: Molecular interactions in the Vogelstein model of colorectal carcinoma. J Pathol 2000; 190:412-416.
7. Leslie A, Carey FA, Pratt NR, Steele RJ: The colorectal adenoma-carcinoma sequence. Br J Surg 2002; 89:845-860. (Pubitemid 34779568)
8. Tsamandas AC, Kardamakis D, Petsas T, Kardamakis D, Petsas T, Zolota V, Vassiliu V, Matatsoris TH, Kalofonos H, Vagianos CE, Scopa CD: Bcl-2, Bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome. In Vivo 2007; 21:113-118. (Pubitemid 46359208)
9. Wang J, Wang X, Gong W, Mi B, Liu S, Jiang B: Increased expression of β-catenin, phosphorylated glycogen synthase kinase 3b, cyclin D1 and c-myc in laterally spreading colorectal tumors. J Histochem Cytochem 2009; 57(4):363-371.
10. Han YD, Hong YK, Kang JG, Choi YJ, Park CH: Relation of the expression of cyclooxygenase-2 in colorectal adenomas and adenocarcinomas to angiogenesis and prognosis. J Korean Soc Coloproctol 2010; 26(5);339-346.
11. Elagoz S, Egilmez R, Koyuncu A, Muslehiddinoglu A, Ariel S: The intratumoral microvessel density and expression of bFGF and nm23-H1 in colorectal cancer. Pathol Oncol Res 2006; 12:21-27.
12. Kallioniemi OP, Wagner U, Kononen J, Sauter G: Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001; 7:657-662. (Pubitemid 32331572)
13. Mucci NR, Akdas G, Manely S, Rubin MA: Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol 2000; 31:406-414. (Pubitemid 30262860)
14. Richter J, Wagner U, Kononen J, et al.: High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 2000; 157:787-794. (Pubitemid 32109371)
15. Kuraya K, Simon R, Sauter G: Tissue microarrays for high-throughput molecular pathology. Ann Saudi Med 2004; 24(3):169-174. (Pubitemid 38931132)
16. Garber K: Beyond the Nobel Price: cell cycle research offers new view on cancer. J Natl Cancer Inst 2001; 93:1766.
17. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75(4):817-825. (Pubitemid 23346378)
18. Chao DT, Korsmayer SJ: BCL-2 family: regulators of cell death. Annu Rev Immuno 1998; 116:395-419. (Pubitemid 28183370)
19. Knudson CM, Korsmeyer SJ: BCL-2 and BAX function independendy to regulate cell death. Nat Genet 1997; 16(4):358-363. (Pubitemid 27323300)
20. Que FG, Gores GJ: Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology 1996; 110:1238-1243. (Pubitemid 26113764)
21. Ilyas M, Hao X-P, Wilkinson K, Tomlinson IPM, Abbasi AM, Forbes A, Bodmer WF, Talbot IC: Loss of bcl-2 expression correlates with tumour recurrence in colorectal cancer. Gut 1998; 43:383-387. (Pubitemid 28414920)
22. Mosnier J-F, Perret AG, Vindimlan M, Dumollard JM, Balique JG, Perpoint B, Boucheron S: An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumours of the colon and rectum. Arch Pathol Lab Med 1996; 120:654-659. (Pubitemid 26244391)
23. Contu PC, Contu SS, Moreira LF: Bcl-2 expression in rectal cancer. Arq Gastroenterol 2006; 43:284-287. (Pubitemid 46556127)
24. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9(6): 1799-1805. (Pubitemid 24163411)
25. Aamodt R, Jonsdottir K, Andersen SN, Bondi J, Bukholm G, Bukholm IRK: Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas. Gastroenterol Res and Pract 2009; 2009:1-9.
26. Aamodt R, Bondi J, Andersen SN, Bukholm G, Bukholm IRK: Expression of nuclear beta-catenin in rectal versus colonic cancers. Open Clin Cancer J 2008; 2:13-17.
27. Maruyama K, Ochiai A, Akimoto S, Nakamura S, Baba S, Moriya Y, Hirohashi S: Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology 2000; 59(4):302-309.
28. Masramon L, Arribas R, Tortola S, Perucho M, Peinado MA: Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer. Br J Cancer 1998; 77(12):2349-2356. (Pubitemid 28263965)
29. Brown JR, DuBois RN: COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol 2005; 23:2840-2855. (Pubitemid 46179475)
30. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107:1183-1188. (Pubitemid 24294584)
31. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T: Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995; 55:3785-3789.
32. Fujita T, Matsui M, Takaku K, Uetake H, Ichikawa W, Taketo MM, Sugihara K: Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res 1998; 58:4823-4826. (Pubitemid 28503676)
33. Dursun A, Akyurek N, Gunel N, Yamac D: Prognostic implication of nm23-H1 expression in colorectal carcinomas. Pathology 2002; 34:427-432. (Pubitemid 35205244)
34. Soliani P, Ziegler S, Romani A, Corcione L, Campanini N, Dell'Abate P, Del Rio P, Sianesi M: Prognostic significance of nm23-H1 gene product expression in patients with colorectal carcinoma treated with radical intent. Oncol Rep 2004; 11:1193-1200.
35. Martinez J A, Prevot S, Nordlinger B, Nguyen T M, Lacarriere Y, Munier A, Lascu I, Vaillant J C, Capeau J, Lacombe ML: Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut 1995; 37:712-720.
36. Dursun A, Akyurek N, Gunel N, Yamac D: Prognostic implication of nm23-H1 expression in colorectal carcinomas. Pathology 2002; 34:427-432. (Pubitemid 35205244)